VolitionRx Appoints LifeSci Advisors as Investor Relations Consultants

Yahoo FinanceDec 12 08:00 ET

Express News | VolitionRX Shares Are Trading Higher After the Company Announced a Study Showed Its Nu.Q Lung Cancer Test Achieved 92% Sensitivity and 89% Positive Predictive Value in Differentiating Malignant From Benign Pulmonary Nodules

BenzingaDec 10 08:52 ET

Express News | VolitionRX Announces Pricing of up to $1.9 Million Registered Direct Offering

ReutersDec 6 09:00 ET

VolitionRx Announces Pricing of up to $1.9 Million Registered Direct Offering

PR NewswireDec 6 09:00 ET

Benchmark Co. Maintains VolitionRX(VNRX.US) With Hold Rating

Moomoo NewsNov 22 07:33 ET · Ratings

VolitionRX (VNRX) Gets a Hold From Benchmark Co.

TipRanksNov 22 07:02 ET · Ratings